Skip to main content

Table 2 Anthropometric variables in diabetic patients with NAFLD

From: Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial

Anthropometric variables Omega-3 (n = 30) Placebo (n = 30) P P
Weight, kg    0.71 0.61
 Baseline 78.0 ± 10.5 77.1 ± 12.5
 Week 12 78.0 ± 11.1 76.8 ± 13.8
 Mean change 0.0 ± 2.3 − 0.3 ± 2.3
BMI, kg/m2    0.59 0.56
 Baseline 30.2 ± 3.6 29.8 ± 4.2
 Week 12 30.2 ± 3.7 29.6 ± 4.5
 Mean change 0.0 ± 0.8 −0.2 ± 0.8
WC, cm    0.59 0.27
 Baseline 106.7 ± 9.1 104.2 ± 9.8
 Week 12 106.1 ± 8.2 104.8 ± 9.6
 Mean change −0.7 ± 3.7 0.6 ± 3.2
  1. P values are computed by independent t-test and data are expressed as mean ± standard deviation (SD)
  2. P: resulted from comparing the means of each variable at the end of the study, between two groups
  3. P: resulted from comparing the mean change from baseline between groups
  4. NAFLD Non-alcoholic fatty liver disease, BMI Body mass index, WC Waist circumference